Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04619589 · ClinicalTrials.gov registry record
Characterization of Dyschromic Hypertrophic Scar
A clinical trial of Hypertrophic Scar and Hyperpigmentation, sponsored by Medstar Health Research Institute.
- Completed
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT04619589 is a study of Hypertrophic Scar and Hyperpigmentation that has completed, run by Medstar Health Research Institute. The registered enrollment target is 50 participants, above the 37-participant average among 7 other Hypertrophic Scar trials with a reported enrollment target (35% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04619589, a study of Hypertrophic Scar and Hyperpigmentation, has completed, sponsored by Medstar Health Research Institute.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Currently, there are limited prevention or treatments available for dyschromia in burn hypertrophic scars (HTSs). The limited available techniques involve transferring melanocytes from unaffected areas to the scar to adjust pigment. These techniques involve the creation of a donor site and do not utilize the cells that may already be present in scars. This study aims to confirm melanocyte presence in regions of hypo- and hyper- pigmented HTS. If melanocytes can be found in regions of hypopigmentation, these scars may be able to be treated in the future by pigmentation stimulators without the need for surgery. Additionally, if pigmentation specific molecules of interest can be found to be up-regulated in hyperpigmented scar, these may be able to be altered by a pharmacotherapy.
Conditions Studied
Study Locations (1)
District of Columbia
- MedStar Washington Hospital Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2019-05-21 |
| Est. Completion | 2023-06-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04619589
The ClinicalTrials.gov registry entry for NCT04619589 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 37-participant average among 7 other Hypertrophic Scar trials with a reported enrollment target (35% higher). The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Hypertrophic Scar appearing as the primary indexed condition, and to 0 interventions.
NCT04619589 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.
Frequently Asked Questions
What is clinical trial NCT04619589 about?
NCT04619589 is a clinical study titled "Characterization of Dyschromic Hypertrophic Scar". Currently, there are limited prevention or treatments available for dyschromia in burn hypertrophic scars (HTSs). The limited available techniques involve transferring melanocytes from unaffected areas to the scar to adjust pigment. These techniques involve the creation of a donor site and do not ut...
What is the current status of trial NCT04619589?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2019-05-21. Estimated completion is 2023-06-28.
What conditions does trial NCT04619589 study?
This clinical trial studies the following conditions: Hypertrophic Scar, Hyperpigmentation, Burn Scar, Hypopigmented Scar.
Who is sponsoring clinical trial NCT04619589?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04619589 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertrophic Scar
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Zinc Oxide Versus Petrolatum Following Skin Surgery
RECRUITING · Early Phase 1
-
Evaluating the Efficacy of Force Modulating Tissue Bridge Device in Preventing Hypertrophic Scars Following Gender-Affirming Mastectomy
RECRUITING · NA
-
Randomized Controlled Trial Examining the Efficacy of Botulinum Toxin in Biopsy Scar Minimization
ACTIVE NOT RECRUITING · Phase 2
-
A Study to Evaluate the Effectiveness and Safety of RXI 109 on the Outcome of Scar Revision Surgery in Healthy Adults
COMPLETED · Phase 2
-
Randomized Control Trial of CO2 Laser to Treat Hypertrophic Burn Scar
COMPLETED · NA
-
Effects of Pulsed Dye and CO2 Laser in Treatment of Hypertrophic Burn Scars.
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.